Data / Form D filings / Somnum Pharma, Inc.
Somnum Pharma, Inc.: Form D filing
Somnum Pharma, Inc., a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2024. The latest, on November 29, 2024, reports $2 million sold of a $2 million offering.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4 EAST 70TH STREET, 9A, New York, NY, 10021
- Phone
- (347) 495-4416
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- New York
- Year incorporated
- 2024
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2046710
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | New notice | $2,000,000 | $2,000,000 | 0 | Nov 18, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Jasulavic | Director | |
| Orrin Devinsky | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Nov 25, 2024 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Somnum Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.